Literature DB >> 10203680

Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta.

E Ophir1, R Tendler, M Odeh, S Khouri, M Oettinger.   

Abstract

We describe 1 case of placenta increta and 1 of placenta percreta, both associated with elevated maternal serum creatine kinase concentration. In patients with placenta previa and ultrasonographic findings of an abnormally adherent placenta, an unexplained elevation in maternal serum creatine kinase level should alert the clinician to the possibility of placenta increta or placenta percreta, with an attendant increase in maternal morbidity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203680     DOI: 10.1016/s0002-9378(99)70683-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Increased levels of cell-free human placental lactogen mRNA at 28-32 gestational weeks in plasma of pregnant women with placenta previa and invasive placenta.

Authors:  Akihiro Kawashima; Akihiko Sekizawa; Walter Ventura; Keiko Koide; Kyouko Hori; Takashi Okai; Yoshida Masashi; Kenichi Furuya; Yoshifumi Mizumoto
Journal:  Reprod Sci       Date:  2013-06-06       Impact factor: 3.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.